FIELD: medicine, infectious diseases, psychotherapy.
SUBSTANCE: method involves antiviral therapy, immune correction with thymus hormones and interferon inductors. Since the first day the relapse symptom method involves prescription of antiox+ (1 capsule per a day) and detox+ (1 capsule, 2 times per a day) for 30 days, profluzak (20 mg, 3 times per a day for 5 days) and then in the dose 20 mg, 1 time per a day for 20 days. Derinate is prescribed topically as installation into urethra in the dose 3-5 ml or with tampon into vagina and with simultaneous prescription of microenemas in the dose 10-40 ml for 10 days. Since 10-14 day in exacerbation period in the proliferative stage of an antiherpetic immune response derinate is prescribed by intramuscular injections in the dose 5 ml, 1 time in a day, 10 injections in total number. Then since 6-th day of exacerbation and intake of profluzak psychotherapy seances are carried out. The first seance of rational psychotherapy involves explanation to a patient in available form mechanism of the disease, the necessity of prolonged treatment and motivation for treatment is enhanced by suggestion. The second psychotherapy seance involves neurolinguistic programming wherein a patient colorful and detailed description of desirable function when he imagines achievement of the desire result, and positive emotional and vegetative symptoms are notes and the conditional-reflect association is formed by tactile contact. Under psychotherapist control a patient imagines "part of person" responsible for achievement of the desire result the patient attention is accented for the desire result and arisen physiological responses are fixed by using tactile contact. Also, new behavior methods are proposed to take for a patient that are directed for achievement of the desire result - avoiding sexual contacts during exacerbation of genital herpes in one of partner and during every month hormonal cycles, avoiding stress situations, and in case of each stress situation significant for patient profluzak has to be intake in a single dose 40 mg, using a condom in sexual contact in the exacerbation period. Patient analyzes the proposed new behavior methods that help avoiding relapses, provide good state of health, promotes to recovery process of genitals recovery and selects at least three the most rationally available for him behavior methods. In the case of the positive response that is controlled by physiological symptoms the result is fixed by tactile contact. The third seance involves the suggestive psychotherapy directed for fixing the attained result. The suggestive therapy seance is carried out once per a week for 6 months. Method provides declining the treatment time, to reduce relapse frequency of genital herpes and to recover the emotional state of patient.
EFFECT: improved treatment method.
2 cl, 3 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR TREATING ALCOHOLISM | 2004 |
|
RU2277941C2 |
METHOD OF TREATING OBESITY IN CASE OF EMOTIOGENIC TYPE OF EATING BEHAVIOR DISORDER | 2004 |
|
RU2264233C2 |
METHOD FOR STRENGTHENING SEXUAL HEALTH IN PERSONS WITH SEXUALLY TRANSMITTED DISEASES AT OBSERVED DEPRESSIVE DISORDERS IN THEM | 2004 |
|
RU2284196C2 |
INTEGRAL SYNERGETIC PSYCHOTHERAPY METHOD FOR ADJUSTING MENTAL STATES AND TREATING THE CASES OF NEUROTIC DISORDERS AND PATHOLOGICAL ADDICTION | 2004 |
|
RU2276999C2 |
METHOD FOR TREATMENT OF HERPES ZOSTER WITH POST-HERPETIC NEURALGIA SYNDROME IN ELDERLY PATIENTS WITH ORGANIC PERSONALITY DISORDER | 2004 |
|
RU2285528C2 |
METHOD OF OPHTHALMOHERPES TREATMENT ASSOCIATED WITH PROLONGED DEPRESSIONS | 2006 |
|
RU2327449C1 |
METHOD FOR TREATING PATIENTS AT KAPOSI'S ECZEMA HERPETICUM AT DEVELOPING CONVERSION DISORDER | 2006 |
|
RU2320345C1 |
METHOD FOR TREATING RECURRENT HERPETIC STOMATITIS CASES AGGRAVATED BY SOMATOPHOROUS PAIN DISORDER | 2005 |
|
RU2304971C2 |
METHOD FOR TREATING THE CASES OF PATHOLOGICAL ATTRACTION | 2004 |
|
RU2277943C2 |
METHOD OF PSYCHOTHERAPY OF FEMALE INFERTILITY | 2018 |
|
RU2687565C1 |
Authors
Dates
2006-02-20—Published
2004-05-05—Filed